Board of Directors
William C. Weldon
Chairman, Board of Directors and Chief Executive Officer
Mary Sue Coleman, Ph.D.
President, University of Michigan
James G. Cullen
Retired President and Chief Operating Officer, Bell Atlantic Corporation
Michael M.E. Johns, M.D.
Chancellor, Emory University
Arnold G. Langbo
Retired Chairman and Chief Executive Officer, Kellogg Company
Susan L. Lindquist, Ph.D.
Member and Former Director, Whitehead Institute for Biomedical Research; Professor of Biology, Massachusetts Institute of Technology
Anne. M. Mulcahy
Chairman and Retired Chief Executive Officer, Xerox Corporation
Leo F. Mullin
Retired Chairman and Chief Executive Officer, Delta Air Lines, Inc.
William D. Perez
Senior Advisor, Greenhill & Co., Inc.; Retired President and Chief Executive Officer, Wm. Wrigley Jr. Company
Charles Prince
Chairman, Sconset Group, LLC; Senior Counselor, Albright Stonebridge Group; Retired Chairman and Chief Executive Officer, Citigroup Inc.
David Satcher, M.D., Ph.D.
Director, Center of Excellence on Health Disparities, Director, Satcher Health Leadership Institute and Poussaint-Satcher-Cosby Chair in Mental Health, Morehouse School of Medicine; Former U.S. Surgeon General
Committees of the Board
Audit
The Audit Committee, comprised entirely of independent Directors, helps the Board oversee the Company’s accounting and reporting practices. It recommends independent public accountants for appointment by the Board and reviews their performance; monitors the adequacy of internal accounting practices, procedures and controls; and reviews all significant changes in accounting policies.
James G. Cullen, Chairman
Mary Sue Coleman, Ph.D.
Leo F. Mullin
Compensation & Benefits
The Compensation & Benefits Committee, comprised entirely of independent Directors, establishes the Company’s executive compensation philosophy and principles and approves the annual compensation and long-term incentives for the Company’s directors and executive officers. The Committee also reviews the philosophy and policies of the non-Board Management Compensation Committee, which determines management compensation and establishes perquisites and other compensation policies for non-executive employees. Additionally, the Committee oversees the management of the various retirement, pension, long-term incentive, savings, health and welfare plans that cover the Company’s employees.
Arnold G. Langbo, Chairman
Michael M. E. Johns, M.D.
William D. Perez
Charles Prince
Finance
The Finance Committee exercises the management authority of the Board during the intervals between Board meetings. The Finance Committee is comprised of the Chairman of the Board and the Presiding Director.
William C. Weldon, Chairman
James G. Cullen
Nominating & Corporate Governance
The Nominating & Corporate Governance Committee, comprised entirely of independent Directors, is responsible for overseeing corporate governance matters, reviewing possible candidates for Board membership and recommending nominees for election. The Committee is also responsible for overseeing the process for performance evaluations of the Board and its committees. Additionally, the Committee reviews the Company’s executive succession plans and executive resources.
Charles Prince, Chairman
James G. Cullen
Arnold G. Langbo
Public Policy
The Public Policy Advisory Committee reviews the Company’s policies, programs and practices on public health issues regarding the environment and the health and safety of employees. The Committee also reviews the Company’s governmental affairs and policies and other public policy issues facing the Company. The Committee advises and makes recommendations to the Board on these issues as appropriate. The Public Policy Advisory Committee is comprised of independent Directors and the Company’s General Counsel and Vice Presidents for Corporate Affairs, Government Affairs and Policy, and Worldwide Operations.
Leo F. Mullin, Chairman
Susan L. Lindquist, Ph.D.
William D. Perez
David Satcher, M.D., Ph.D.
Russell C. Deyo
Clifford E. Holland
Brian D. Perkins
Ajit Shetty, Ph.D.
Science & Technology
The Science & Technology Advisory Committee, comprised of independent Directors and the Company’s Vice President, Science and Technology, advises the Board on scientific matters, including major internal projects, interaction with academic and other outside research organizations, and the acquisition of technologies and products.
David Satcher, M.D., Ph.D., Chairman
Mary Sue Coleman, Ph.D.
Michael M. E. Johns, M.D.
Susan L. Lindquist, Ph.D.
Garry Neil, M.D.
Corporate Officers
Executive Committee
William C. Weldon
Chairman, Board of Directors
Chief Executive Officer
Chairman, Executive Committee
Dominic J. Caruso
Vice President, Finance
Chief Financial Officer
Executive Committee
Stephen J. Cosgrove
Corporate Controller
Laverne H. Council
Vice President,
Chief Information Officer
Russell C. Deyo
Vice President, General Counsel
Executive Committee
Colleen A. Goggins
Worldwide Chairman,
Consumer Group
Executive Committee
ALEX GORSKY
Worldwide Chairman,
Medical Devices &
Diagnostics Group
Executive Committee
Raymond C. Jordan
Vice President, Public Affairs &
Corporate Communication
Sherilyn S. McCoy
Worldwide Chairman,
Pharmaceuticals Group
Executive Committee
John A. Papa
Treasurer
Brian D. Perkins
Vice President,
Corporate Affairs
Steven M. Rosenberg
Secretary,
Associate General Counsel
The Executive Committee of Johnson & Johnson is the principal management group responsible for the operations and allocation of the resources of the Company. This Committee oversees and coordinates the activities of the Consumer, Pharmaceuticals and Medical Devices and Diagnostics business segments. Each subsidiary within the business segments is, with some exceptions, managed by citizens of the country where it is located.